CD274 and mismatch repair cancer syndrome 1: At the same time, several studies focused on other potential biomarkers such as mismatch repair deficiency [53], mutational load [54] and the composition of the gut microbiome [55] and its interaction with PD-1/PD-L1 inhibitors need to be further explored.